Roivant Sciences Ltd. Contracts & Agreements

59 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Retention Award Agreement between Roivant Sciences, Inc. and Mayukh Sukhatme
Retention Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2025
Roivant Sciences Inc. One-Time Retentive Cash Award Statement for [NAME]
Bonus & Incentive Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2025
Roivant Sciences Ltd. Performance Restricted Stock Unit Award Grant Notice (2021 Equity Incentive Plan)
Bonus & Incentive Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2025
Separation Agreement and General Release between Roivant Sciences, Inc. and Rakhi Kumar
Separation Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2025
Consulting Agreement between Roivant Sciences, Inc. and Rakhi Kumar dated March 16, 2025
Consulting Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2025
License Agreement between Bayer Aktiengesellschaft and Pulmovant, Inc.
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Amendment to License Agreement between Bayer Aktiengesellschaft and Pulmovant, Inc.
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2024
First Amendment to Credit Agreement among Dermavant Sciences Ltd., Subsidiaries, XYQ Luxco S.à r.l., and U.S. Bank Trust Company
Credit Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Second Amendment to Funding Agreement among Dermavant Sciences GmbH, Dermavant Sciences Ltd., and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
First Amendment to Revenue Interest Purchase and Sale Agreement among Dermavant Sciences GmbH, Dermavant Sciences, Ltd., XYQ Luxco S.À R.L., NovaQuest Co-Investment Fund XVII,...
Modification Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Executive Employment Agreement between Roivant Sciences, Inc. and Richard Pulik
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Executive Employment Agreement between Roivant Sciences, Inc. and Rakhi Kumar (Chief Accounting Officer)
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Stock Purchase Agreement among Roche Holdings, Inc., Roivant Sciences Ltd., Pfizer Inc., and Telavant Holdings, Inc. dated October 22, 2023
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Common Share Purchase and Sale Agreement between Roivant Sciences Ltd. and Investors (September 2023)
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Description of Roivant Sciences Ltd. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Employee Stock Purchase Plan (as amended March 27, 2023)
Stock Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Roivant Sciences Ltd. Stock Option Grant Notice under Amended and Restated 2015 Equity Incentive Plan
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Restricted Stock Unit Award Grant Notice (2015 Equity Incentive Plan)
Bonus & Incentive Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. 2015 Equity Incentive Plan Performance Option Grant Agreement with Optionholder
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. 2015 Equity Incentive Plan Capped Value Appreciation Right Award Grant Notice
Bonus & Incentive Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Stock Option Grant Notice and Option Agreement (2021 Equity Incentive Plan)
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Restricted Stock Unit Award Grant Notice and Agreement (2021 Equity Incentive Plan)
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Separation and Mutual Release Agreement between Roivant Sciences, Inc. and Vivek Ramaswamy (February 20, 2023)
Separation Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
License and Collaboration Agreement between Pfizer Inc. and Licensee (with Roivant Sciences Ltd. for Section 11.4) dated November 21, 2022
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Investor Rights Agreement among Roivant Sciences Ltd., Pfizer Inc., and Other Investors, Dated November 21, 2022
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2023
Underwriting Agreement for Sale of 26,666,666 Common Shares by Roivant Sciences Ltd. to Underwriters Led by Goldman Sachs & Co. LLC
Underwriting Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Partial Termination and Supplementary Fee Agreement between GlaxoSmithKline Trading Services Limited and Dermavant Sciences GmbH (July 25, 2022)
Termination Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Master Commercial Manufacturing and Supply Agreement between Dermavant Sciences GmbH and Thermo Fisher Scientific Cork Limited
Supply Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Underwriting Agreement between Roivant Sciences Ltd., Selling Shareholders, and Cantor Fitzgerald & Co. (November 8, 2022)
Underwriting Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Third Amended and Restated Registration Rights Agreement among Roivant Sciences Ltd. and Certain Investors
Registration Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Subscription Agreement among Montes Archimedes Acquisition Corp., Investor, and Roivant Sciences Ltd.
Subscription Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Sponsor Support Agreement among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., and Patient Square Capital LLC (May 1, 2021)
Shareholders Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Transaction Support Agreement among Montes Archimedes Acquisition Corp., Roivant Sciences Ltd., and Shareholder
Cooperation Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Amendment No. 1 to Sponsor Support Agreement among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., Patient Square Capital LLC, and Insiders
Modification Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Investor Rights Agreement among Priovant Holdings, Inc., Roivant Sciences Ltd., and Pfizer Inc. dated September 13, 2021
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
License and Collaboration Agreement between Pfizer Inc. and Priovant, Inc. dated September 13, 2021
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
First Amendment to License and Collaboration Agreement between Pfizer Inc. and Priovant Therapeutics, Inc.
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Exclusive License Agreement between Eisai Co. Ltd. and Pharmavant 7 GmbH (November 24, 2021)
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Common Shares Purchase Agreement between Roivant Sciences Ltd. and CF Principal Investments LLC (February 14, 2022)
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Third Amendment to Cross License Agreement between Genevant Sciences GmbH and Arbutus Biopharma Corporation
License Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Roivant Sciences, Inc. Bonus Letter Agreement with Benjamin Zimmer (Datavant Transaction)
Bonus & Incentive Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Agreement and General Release between Roivant Sciences, Inc. and Benjamin Zimmer regarding Employment Transfer to Priovant, Inc.
Separation Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Amendment No. 2 to Sponsor Support Agreement among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., and Shareholders
Modification Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Asset Purchase Agreement by and among GlaxoSmithKline Intellectual Property Development Ltd., Glaxo Group Limited, and Dermavant Sciences GmbH, dated July 10, 2018
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Asset Purchase Agreement between Glaxo Group Limited and Welichem Biotech Inc.
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Amendment Number One to Asset Purchase Agreement between Glaxo Group Limited and Welichem Biotech, Inc.
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Clinical Manufacturing and Supply Agreement between GlaxoSmithKline Trading Services Limited and Dermavant Sciences GmbH (Tapinarof and Clinical Placebo)
Supply Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Commercial Manufacturing and Supply Agreement between GlaxoSmithKline Trading Services Limited and Dermavant Sciences GmbH (Tapinarof)
Supply Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P. Funding Agreement (July 10, 2018)
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
First Amendment to Funding Agreement between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2021
Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (as Amended March 26, 2020)
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Roivant Sciences Ltd. 2021 Equity Incentive Plan
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Amended and Restated Employment Agreement between Roivant Sciences, Inc. and Vivek Ramaswamy (May 14, 2021)
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Executive Employment Agreement between Roivant Sciences, Inc. and Matthew Gline (May 14, 2021)
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Executive Employment Agreement between Roivant Sciences, Inc. and Eric Venker (May 14, 2021)
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Executive Employment Agreement between Roivant Sciences, Inc. and Benjamin Zimmer (May 14, 2021)
Employment Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Business Combination Agreement among Montes Archimedes Acquisition Corp., Rhine Merger Sub, Inc., and Roivant Sciences Ltd. dated May 1, 2021
Merger Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Amendment No. 1 to Business Combination Agreement between Montes Archimedes Acquisition Corp. and Roivant Sciences Ltd.
Merger Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Collaboration and License Agreement between Dermavant Sciences GmbH and Japan Tobacco Inc. (Tapinarof/DMVT-505)
Collaboration Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021